Research workspace · registry aware

Cancer Research Platform

A pipeline-guided workspace for molecular characterization, evidence exchange, and reproducible research reporting.

Explore the pipeline

Cancer Discovery Pipeline

Seven-stage research framework
  1. Data
  2. Molecular state
  3. Biomarkers
  4. Vulnerabilities
  5. Pharmacology
  6. Validation
  7. Report

Data & Methods

Declared sources, schemas, and validation gates.

Dataset references describe intended inputs. Planned registration does not imply that data has been downloaded, harmonized, or approved for analysis.

Dataset contracts

Inputs referenced by registered modules

Open dataset registry
planned

DEPMAP_CRISPR_GENE_EFFECT

DEPMAP_CRISPR_GENE_EFFECT

Planned harmonized CRISPR gene-effect dataset; release and semantics are not yet locked.

Source
Cancer Dependency Map
Version
pending-source-lock
Layer
CURATED
Required by
P002
planned

GDC_TCGA_BRCA_CASE_METADATA

GDC_TCGA_BRCA_CASE_METADATA

Planned immutable TCGA-BRCA case/sample metadata source snapshot required for deterministic research-cohort construction; no source snapshot is locked. Curated linkages receive a separate dataset identity.

Source
NCI Genomic Data Commons
Version
pending-source-lock
Layer
RAW
Required by
P001
planned

GDC_TCGA_BRCA_RNA

GDC_TCGA_BRCA_RNA

Planned immutable TCGA-BRCA STAR Counts source dataset; the GDC source release and file inventory are not yet locked. Curated expression receives a separate dataset identity.

Source
NCI Genomic Data Commons
Version
pending-source-lock
Layer
RAW
Required by
P001, P002
planned

GDC_TCGA_BRCA_SOMATIC_MUTATIONS

GDC_TCGA_BRCA_SOMATIC_MUTATIONS

Planned immutable open TCGA-BRCA masked somatic mutation MAF source dataset; the GDC source release and file inventory are not yet locked. Curated mutation data receives a separate dataset identity.

Source
NCI Genomic Data Commons
Version
pending-source-lock
Layer
RAW
Required by
P001
planned

GDSC_DRUG_RESPONSE

GDSC_DRUG_RESPONSE

Planned harmonized GDSC response dataset; licensed release and response semantics are unresolved.

Source
Genomics of Drug Sensitivity in Cancer
Version
pending-source-lock
Layer
CURATED
Required by
P002
planned

PDC_PROTEOMICS

PDC_PROTEOMICS

Planned harmonized proteomics dataset; study, source release, and processing are unresolved.

Source
NCI Proteomic Data Commons
Version
pending-source-lock
Layer
CURATED
Required by
P002
planned

PRISM_DRUG_RESPONSE

PRISM_DRUG_RESPONSE

Planned harmonized PRISM response dataset; release, dose, and viability semantics are unresolved.

Source
PRISM Repurposing
Version
pending-source-lock
Layer
CURATED
Required by
P002

Typed exchange

Artifact schema contracts

These types define potential evidence exchange; they are not published result records.

  • CandidateVulnerabilitySchema 1.0.0
  • DrugResponseEvidenceSchema 1.0.0
  • FunctionalDependencySchema 1.0.0
  • ProteinValidationEvidenceSchema 1.0.0

Validation lifecycle

Declared quality gates

Gate presence is a contract requirement, not proof that a gate has passed.

  1. G0

    Required validation checkpoint

  2. G1

    Required validation checkpoint

  3. G2

    Required validation checkpoint

  4. G3

    Required validation checkpoint

  5. G4

    Required validation checkpoint

  6. G5

    Required validation checkpoint

  7. G6

    Required validation checkpoint

  8. G7

    Required validation checkpoint